306 related articles for article (PubMed ID: 3003590)
1. Further evidence for, and nature of, the facilitatory GABAergic influence on central noradrenergic transmission.
Dennis T; Curet O; Nishikawa T; Scatton B
Naunyn Schmiedebergs Arch Pharmacol; 1985 Nov; 331(2-3):225-34. PubMed ID: 3003590
[TBL] [Abstract][Full Text] [Related]
2. Evidence for the involvement of presynaptic alpha-2 adrenoceptors in the regulation of norepinephrine metabolism in the rat brain.
Curet O; Dennis T; Scatton B
J Pharmacol Exp Ther; 1987 Jan; 240(1):327-36. PubMed ID: 3027307
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory influence of GABA on central serotonergic transmission. Involvement of the habenulo-raphé pathways in the GABAergic inhibition of ascending cerebral serotonergic neurons.
Nishikawa T; Scatton B
Brain Res; 1985 Apr; 331(1):81-90. PubMed ID: 2985200
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory influence of GABA on central serotonergic transmission. Raphé nuclei as the neuroanatomical site of the GABAergic inhibition of cerebral serotonergic neurons.
Nishikawa T; Scatton B
Brain Res; 1985 Apr; 331(1):91-103. PubMed ID: 2985201
[TBL] [Abstract][Full Text] [Related]
5. Fengabine, a novel antidepressant GABAergic agent. II. Effect on cerebral noradrenergic, serotonergic and GABAergic transmission in the rat.
Scatton B; Lloyd KG; Zivkovic B; Dennis T; Claustre Y; Dedek J; Arbilla S; Langer SZ; Bartholini G
J Pharmacol Exp Ther; 1987 Apr; 241(1):251-7. PubMed ID: 3033204
[TBL] [Abstract][Full Text] [Related]
6. Brain 3,4-dihydroxyphenylethyleneglycol levels are dependent on central noradrenergic neuron activity.
Scatton B
Life Sci; 1982 Aug; 31(5):495-504. PubMed ID: 7132563
[TBL] [Abstract][Full Text] [Related]
7. GABA receptor agonists: pharmacological spectrum and therapeutic actions.
Bartholini G
Med Res Rev; 1985; 5(1):55-75. PubMed ID: 2984490
[TBL] [Abstract][Full Text] [Related]
8. The spinal GABA system modulates burst frequency and intersegmental coordination in the lamprey: differential effects of GABAA and GABAB receptors.
Tegnér J; Matsushima T; el Manira A; Grillner S
J Neurophysiol; 1993 Mar; 69(3):647-57. PubMed ID: 8385187
[TBL] [Abstract][Full Text] [Related]
9. GABA mimetics increase extracellular DOPAC (as measured by in vivo voltammetry) in the rat locus coeruleus.
Scatton B; Serrano A
Naunyn Schmiedebergs Arch Pharmacol; 1986 Apr; 332(4):380-3. PubMed ID: 3736682
[TBL] [Abstract][Full Text] [Related]
10. GABAergic mechanisms of analgesia: an update.
Sawynok J
Pharmacol Biochem Behav; 1987 Feb; 26(2):463-74. PubMed ID: 3033701
[TBL] [Abstract][Full Text] [Related]
11. Release-regulating GABAA receptors are present on noradrenergic nerve terminals in selective areas of the rat brain.
Bonanno G; Raiteri M
Synapse; 1987; 1(3):254-7. PubMed ID: 2850623
[TBL] [Abstract][Full Text] [Related]
12. Possible physiological significance of the initial step in the catabolism of noradrenaline in the central nervous system of the rat.
Farah MB; Adler-Graschinsky E; Langer SZ
Naunyn Schmiedebergs Arch Pharmacol; 1977 Mar; 297(2):119-31. PubMed ID: 585416
[TBL] [Abstract][Full Text] [Related]
13. Effect of postnatal exposure to GABA agonist muscimol on age-related changes in hypothalamic noradrenaline concentration in rats.
Taira T; Smith SE
Neurotoxicol Teratol; 1993; 15(3):211-4. PubMed ID: 8393132
[TBL] [Abstract][Full Text] [Related]
14. gamma-Aminobutyric acid (GABA) receptor stimulation. II. Specificity of progabide (SL 76002) and SL 75102 for the GABA receptor.
Lloyd KG; Arbilla S; Beaumont K; Briley M; De Montis G; Scatton B; Langer SZ; Bartholini G
J Pharmacol Exp Ther; 1982 Mar; 220(3):672-7. PubMed ID: 6121050
[TBL] [Abstract][Full Text] [Related]
15. In vivo measurement of noradrenaline and 3,4-dihydroxyphenylethyleneglycol in the rat hypothalamus by microdialysis: effects of various drugs affecting noradrenaline metabolism.
Itoh Y; Oishi R; Nishibori M; Saeki K
J Pharmacol Exp Ther; 1990 Dec; 255(3):1090-7. PubMed ID: 2262894
[TBL] [Abstract][Full Text] [Related]
16. Evidence for gamma-aminobutyric acid modulation of ovarian hormonal effects on luteinizing hormone secretion and hypothalamic catecholamine activity in the female rat.
Adler BA; Crowley WR
Endocrinology; 1986 Jan; 118(1):91-7. PubMed ID: 3510124
[TBL] [Abstract][Full Text] [Related]
17. Effects of clonidine on the rate of noradrenaline turnover in discrete areas of the rat central nervous system.
Lorez HP; Kiss D; Da Prada M; Haeusler G
Naunyn Schmiedebergs Arch Pharmacol; 1983 Aug; 323(4):307-14. PubMed ID: 6633671
[TBL] [Abstract][Full Text] [Related]
18. Pharmacology of the GABAergic system: effects of progabide, a GABA receptor agonist.
Bartholini G
Psychoneuroendocrinology; 1984; 9(2):135-40. PubMed ID: 6089242
[TBL] [Abstract][Full Text] [Related]
19. The inhibitory GABAergic influence on striatal serotonergic neurons depends upon the habenulo-raphe pathways.
Nishikawa T; Scatton B
Brain Res; 1984 Jun; 304(1):157-61. PubMed ID: 6331579
[TBL] [Abstract][Full Text] [Related]
20. Primary afferents evoke excitatory amino acid receptor-mediated EPSPs that are modulated by presynaptic GABAB receptors in lamprey.
Christenson J; Grillner S
J Neurophysiol; 1991 Dec; 66(6):2141-9. PubMed ID: 1687474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
